Taken together, although tPA is the only approved treatment for acute ischemic stroke, cell-based therapy, especially BMSCs-based therapy, has also been shown to enhance function recovery, ameliorate cognitive dysfunction, and improve neuroplasticity after stroke. The gene discussed is PLAT; the disease is stroke disorder.